CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
52.06
+1.07 (2.10%)
At close: Apr 28, 2026, 4:00 PM EDT
51.97
-0.09 (-0.17%)
After-hours: Apr 28, 2026, 7:52 PM EDT

CRISPR Therapeutics AG Statistics

Total Valuation

CRSP has a market cap or net worth of $5.01 billion. The enterprise value is $3.25 billion.

Market Cap 5.01B
Enterprise Value 3.25B

Important Dates

The next estimated earnings date is Monday, May 11, 2026, after market close.

Earnings Date May 11, 2026
Ex-Dividend Date n/a

Share Statistics

CRSP has 96.32 million shares outstanding. The number of shares has increased by 6.60% in one year.

Current Share Class 96.32M
Shares Outstanding 96.32M
Shares Change (YoY) +6.60%
Shares Change (QoQ) +4.34%
Owned by Insiders (%) 0.45%
Owned by Institutions (%) 78.96%
Float 95.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1,429.12
Forward PS 177.65
PB Ratio 2.60
P/TBV Ratio 2.61
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 925.11
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.32, with a Debt / Equity ratio of 0.11.

Current Ratio 13.32
Quick Ratio 13.25
Debt / Equity 0.11
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -30.18% and return on invested capital (ROIC) is -312.24%.

Return on Equity (ROE) -30.18%
Return on Assets (ROA) -15.76%
Return on Invested Capital (ROIC) -312.24%
Return on Capital Employed (ROCE) -26.86%
Weighted Average Cost of Capital (WACC) 13.56%
Revenue Per Employee $8,931
Profits Per Employee -$1.48M
Employee Count 393
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

In the past 12 months, CRSP has paid $3.63 million in taxes.

Income Tax 3.63M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +36.03% in the last 52 weeks. The beta is 1.79, so CRSP's price volatility has been higher than the market average.

Beta (5Y) 1.79
52-Week Price Change +36.03%
50-Day Moving Average 52.60
200-Day Moving Average 56.51
Relative Strength Index (RSI) 48.71
Average Volume (20 Days) 1,772,384

Short Selling Information

The latest short interest is 22.75 million, so 23.62% of the outstanding shares have been sold short.

Short Interest 22.75M
Short Previous Month 22.62M
Short % of Shares Out 23.62%
Short % of Float 23.73%
Short Ratio (days to cover) 13.95

Income Statement

In the last 12 months, CRSP had revenue of $3.51 million and -$581.60 million in losses. Loss per share was -$6.47.

Revenue 3.51M
Gross Profit -494.78M
Operating Income -568.32M
Pretax Income -577.97M
Net Income -581.60M
EBITDA -548.84M
EBIT -568.32M
Loss Per Share -$6.47
Full Income Statement

Balance Sheet

The company has $1.98 billion in cash and $206.75 million in debt, giving a net cash position of $1.77 billion or $18.37 per share.

Cash & Cash Equivalents 1.98B
Total Debt 206.75M
Net Cash 1.77B
Net Cash Per Share $18.37
Equity (Book Value) 1.92B
Book Value Per Share 20.04
Working Capital 1.84B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$345.01 million and capital expenditures -$914,000, giving a free cash flow of -$345.93 million.

Operating Cash Flow -345.01M
Capital Expenditures -914,000
Depreciation & Amortization 19.48M
Net Borrowing n/a
Free Cash Flow -345.93M
FCF Per Share -$3.59
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -16,191.40%
Pretax Margin -16,466.24%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRSP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.60%
Shareholder Yield -6.60%
Earnings Yield -11.59%
FCF Yield -6.90%

Analyst Forecast

The average price target for CRSP is $70.29, which is 35.02% higher than the current price. The consensus rating is "Buy".

Price Target $70.29
Price Target Difference 35.02%
Analyst Consensus Buy
Analyst Count 17
Revenue Growth Forecast (5Y) 119.16%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CRSP has an Altman Z-Score of 6.78 and a Piotroski F-Score of 1.

Altman Z-Score 6.78
Piotroski F-Score 1